Skip to main content
All lobbying clients

NEVRO CORPORATION

Lobbying client · California · filed 2025 to 2025

Medical device company specializing in neuromodulation for the treatment of chronic pain.

$80,000 Reported spend
3 Filings counted
1 Outside firm hired
0 Bills named

Spend is reported income plus in-house expenses across 3 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. Everything on this page comes from one LDA client record (153958), filed by the registrant listed below.

 Who filed for this client 1

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 1 year
  • 2025 $80,000 3 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 2
  • SENATE 2
 Recent filings 4 total
Q3 termination amendmentNo activity
JEFFREY J. KIMBELL & ASSOCIATES, INC.
3rd Quarter 2025 (July 1 - Sep 30) · posted Apr 20, 2026
View → Q3 terminationNo activity
JEFFREY J. KIMBELL & ASSOCIATES, INC. Amended
3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 20, 2025
View → Q2 termination
JEFFREY J. KIMBELL & ASSOCIATES, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 18, 2025
View → Q1 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 17, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem